UNLOXCYT (cosibelimab)

**Product type:** Human Prescription Drug

**Active ingredient:** COSIBELIMAB

**Strength:** 300 mg/5mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Sun Pharmaceutical Industries, Inc.

**Marketing category:** BLA (BLA761297)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Programmed Death Ligand-1 Antagonists [MoA], Programmed Death Ligand-1 Blocker [EPC], Programmed Death Ligand-1-directed Antibody Interactions [MoA]